Comparison of analgesic efficacy of acetaminophen monotherapy versus acetaminophen combinations with either pethidine or parecoxib in patients undergoing laparoscopic cholecystectomy: a randomized prospective study
Aim To investigate analgesic effect of three different regimens of combination of analgesics administered to patients undergoing laparoscopic cholecystectomy. Methods Patients undergoing laparoscopic cholecystectomy were randomly allocated to one of three groups on admission, depending of a prescribed post-operative analgesic regimen. Patients allocated to the group A received a combination of intravenous (IV) acetaminophen and intramuscular (IM) pethidine, patients in the group B received a combination of IV acetaminophen and IV parecoxib, and the patients of the group C received IV acetaminophen monotherapy. Analgesic therapy was administered at regular intervals. Pain was evaluated utilizing the numeric rating scale (NRS) at 5 time points: the first assessment was done at 45 minutes, the second, third, fourth and fifth at 2, 6, 12, and 24 hours post-administration, respectively. Postoperative pain intensity was measured by NRS within the groups and between the groups at each time they analysed using one-way repeat measured ANOVA and Post Hoc Test-Bonferroni Correlation. Results A total of 316 patients were enrolled. The analgesic regimens of groups A and B (combination regimens consisting of IV acetaminophen and intramuscular pethidine and IV acetaminophen and IV parecoxib, respectively) were found to be of equivalent efficacy (p=1.000). In contrast, patients in group C (acetaminophen monotherapy) had higher NRS scores, compared to both patients in groups A (p<0.01) and B (p<0.01). Conclusion This study confirms the notion of a significant opioid-sparing effect of parecoxib in postoperative pain management after laparoscopic cholecystectomy.
Kapoor T, Wrenn S, Callas P. Abu-Jaish W. Cost analysis and supply utilization of laparoscopic cholecystectomy. Minim Invasive Surg. 2018. p. 7838103.
2.
Kiriyama S, Takada T, Strasberg S, Solomkin J, Mayumi T, Pitt H, et al. New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012. p. 548–56.
3.
Choi G, Kang H, Baek C, Jung Y, Kim D. Effect of intraperitoneal local anesthetic on pain characteristics after laparoscopic cholecystectomy. World J Gastroenterol. 2015. p. 13386–95.
4.
Bisgaard T, Kehlet H, Rosenberg J. Pain and convalescence after laparoscopic cholecystectomy. Eur J Surg. 2001. p. 84–96.
5.
Bisgaard T, Klarskov B, Rosenberg J, Kehlet H. Factors determining convalescence after uncomplicated laparoscopic cholecystectomy. Arch Surg. 2001. p. 917–21.
6.
Morsy K, Abdalla M, E. Postoperative pain relief after laparoscopic cholecystectomy: intraperitoneal lidocaine versus nalbuphine. Ain-Shams J Anaesthesiol. 2014. p. 40–4.
7.
Alkhamesi N, Peck D, Lomax D, Darzi A. Intraperitoneal aerosolization of bupivacaine reduces postoperative pain in laparoscopic surgery: a randomized prospective controlled double-blinded clinical trial. DarziSurg Endosc. 2007. p. 602–6.
8.
Acharya R, Karan D, Khetan M. Postoperative analgesia with intraperitoneal ropivacaine with and without dexmedetomidine after total laparoscopic hysterectomy: a randomized, double-blind, controlled trial. Asian J Pharm Clin Res. 2016. p. 76–9.
9.
Saadati K, Razavi M, Salman N, Izadi D, S. Postoperative pain relief after laparoscopic cholecystectomy: intraperitoneal sodium bicarbonate versus normal saline. Gastroenterol Hepatol Bed Bench. 2016. p. 189–96.
10.
Munsterhjelm E, Niemi T, Ylikorkala O, Neuvonen P, Rosenberg P. Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers. Br J Anaesth. 2006. p. 226–31.
11.
Slater D, Kunnathil S, Mcbride J, Koppala R. Pharmacology of nonsteroidal antiinflammatory drugs and opioids. Semin Intervent Radiol. 2010. p. 400–11.
12.
Graham G, Davies M, Day R, Mohamudally A, Scott K. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013. p. 201–32.
13.
Gehling M, Arndt C, Eberhart L, Koch T, Kruger T, Wulf H. Postoperative analgesia with parecoxib, acetaminophen, and the combination of both: a randomized, double-blind, placebo-controlled trial in patients undergoing thyroid surgery. Br J Anaesth. 2010. p. 761–7.
14.
Ng A, Parker J, Toogood L, Cotton B, Smith G. Does the opioid-sparing effect of rectal diclofenac following total abdominal hysterectomy benefit the patient? Br J Anaesth. 2002. p. 714–6.
15.
Schüchen R, Mücke M, Marinova M, Kravchenko D, Häuser W, Radbruch L, et al. Systematic review and meta-analysis on non-opioid analgesics in palliative medicine. J Cachexia Sarcopenia Muscle. 2018. p. 1235–54.
16.
De Cassai A, Boscolo A, Tonetti T, Ban I, Ori C. Assignment of ASA-physical status relates to anesthesiologists’ experience: a survey-based nationalstudy. Korean J Anesthesiol. 2019. p. 53–9.
17.
Pathak A, Sharma S, Jensen M. The utility and validity of pain intensity rating scales for use in developing countries. Pain Rep. 2018. p. 672.
18.
Shagufta F, Zankhana M, Carlos F, Bertarnd B. Mellar D. A comparison of Numeric Pain Rating Scale (NPRS) and the Visual Analog Scale (VAS) in patients with chronic cancer-associated pain. J Clin Oncol. 2017. p. 217.
19.
Safikhani S, Gries K, Trudeau J, Reasner D, Rüdell K, Coons S, et al. Response scale selection in adult pain measures: results from a literature review. J Patient Rep Outcomes. 2018. p. 40.
20.
Nong L, Sun Y, Tian Y, Li H, Li H. Effects of parecoxib on morphine analgesia after gynecology tumor operation: A randomized trial of parecoxib used in postsurgical pain management. J Surg Res. 2013. p. 821–6.
21.
Fu W, Yao J, Li Q, Wang Y, Wu X, Zhou Z, et al. Efficacy and safety of parecoxib/phloroglucinol combination therapy versus parecoxib monotherapy for acute renal colic: a randomized, double-blind clinical trial. Cell Biochem Biophys. 2014. p. 157–61.
22.
Essex M, Xu H, Parsons B, Xie L, Li C. Parecoxib relieves pain and has an opioid-sparing effect following major gastrointestinal surgery. Int J Gen Med. 2017. p. 319–27.
23.
Baharuddin K, Rahman N, Wahab S, Halim N, Ahmad R. Intravenous parecoxib sodium as an analgesic alternative to morphine in acute trauma pain in the emergency department. Int J Emerg Med. 2014. p. 2.
24.
Siribumrungwong K, Cheewakidakarn J, Tangtrakulwanich B, Nimmaanrat S. Comparing parecoxib and ketorolac as preemptive analgesia in patients undergoing posterior lumbar spinal fusion: a prospective randomized double-blinded placebo-controlled trial. BMC Musculoskelet Disord. 2015. p. 59.
25.
George B, Zahid H, Derek J, Richard L, C. A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy. Am J Obstet Gynecol. 2004. p. 1183–91.
26.
Diaz-Borjon E, Torres-Gomez A, Essex M, Salomon P, Li C, Cheung R, et al. Parecoxib provides analgesic and opioid-sparing effects following major orthopedic surgery: a subset analysis of a randomized, placebo-controlled clinical trial. Pain Ther. 2017. p. 61–72.
27.
Liu W, Shu H, Zhao G, Peng S, Xiao J, Zhang G, et al. Effect of parecoxib as an adjunct to patient-controlled epidural analgesia after abdominal hysterectomy: a multicenter, randomized, placebo-controlled trial. PLoS One. 2016. p. 162589.
28.
Shen S, Peng P, Chen H, Lin J, Lee M, Yu H. Analgesic effects of intra-articular bupivacaine/ intravenous parecoxib combination therapy versus intravenous parecoxib monotherapy in patients receiving total knee arthroplasty: a randomized, double-blind trial. Biomed Res Int. 2015. p. 450805.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
